Topline data were announced from a phase 3b trial evaluating the concomitant use of ixekizumab and tirzepatide in active PsA and obesity.

A new winter storm is on track to bring widespread snow, a wintry mix, and gusty winds to the Northeast, with hazardous ...

The TOGETHER-PsA study shows that combining ixekizumab with tirzepatide leads to significantly better psoriatic arthritis ...

UCB Canada Inc. is pleased to announce Health Canada has granted a Notice of Compliance (NOC) for PrBIMZELX® (bimekizumab injection) indicated for the treatment of adult patients with moderate to ...

Abstract: An optimized formation controller for multiple quadrotors is proposed in this paper. The formation control is implemented using a hybrid approach which combines the Virtual Structure and ...